Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2025-520820-44-00Phase 4Authorised
Phase 4 trial of ropivacaine and lidocaine in chronic tonsillitis (2 arms), sponsored by Tauernklinikum. Primary endpoint: Average postoperative pain score within first 72 hours. Planned start Jun 2025; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2025-520820-44-00.